4//SEC Filing
Golumbeski George 4
Accession 0001562180-25-000164
CIK 0001597553other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:02 PM ET
Size
7.7 KB
Accession
0001562180-25-000164
Insider Transaction Report
Form 4
Golumbeski George
Director
Transactions
- Award
Stock Options (Right to buy)
2025-01-03+13,593→ 13,593 totalExercise: $6.14Exp: 2035-01-03→ Common Stock (13,593 underlying)
Footnotes (1)
- [F1]The reporting person elected to receive this stock option award in lieu of payment of all cash retainers that would otherwise be paid for the reporting person's service during 2025 on the issuer's board or its committees, as permitted under the issuer's non-employee director compensation program. The stock option is granted under and subject to the terms of the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. The option will vest in full on December 31, 2025, subject to the reporting person's continued service through such date.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001586660
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:02 PM ET
- Size
- 7.7 KB